News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Khan Samina
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Khan Samina (SVP, Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 288 shares
@ $85.32, valued at
$24.6k
Sold 352 shares
@ $81.368, valued at
$28.6k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/08/2023 |
4
| Khan Samina (SVP, Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 3,961 shares
@ $83.46, valued at
$330.6k
|
|
| 03/06/2023 |
4
| Khan Samina (SVP, Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 3,395 shares
@ $83.7, valued at
$284.2k
Sold 18,956 shares
@ $85.02, valued at
$1.6M
Sold 2,649 shares
@ $85.38, valued at
$226.2k
Sold 2,813 shares
@ $87.36, valued at
$245.7k
Exercised 25,000 options to buy
@ $27.32, valued at
$683k
|
|
| 01/04/2023 |
4
| Khan Samina (SVP, Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 11,756 shares
@ $0
Granted 47,738 options to buy
@ $36.71, valued at
$1.8M
|
|
| 02/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|